silo.ai
  • Services
  • Solutions
  • Work
  • Research
  • Contact
  • •••
    • About
    • Careers
    • Learn
Menu
  • Services
  • Solutions
  • Work
  • Research
  • Contact
  • •••
    • About
    • Careers
    • Learn
silo.ai
  • Services
  • Solutions
  • Research
  • About
  • Careers
  • Learn
  • Contact
Menu
  • Services
  • Solutions
  • Research
  • About
  • Careers
  • Learn
  • Contact
Article / 
Smart Devices & Networks

Automatically grading the severity of prostate cancer in scanned and digitized biopsies

  • May 28, 2020

The machine learning community Kaggle invites the global machine learning talent to tackle different competitions posed by various companies and organizations. This time, two of our AI experts, Mikko Tukiainen and Joni Juvonen are participating in a challenge aiming to improve diagnostics with computer vision. Together with a third machine learning expert Antti Karlsson, their team rähmä.ai is now after to automatically grade the severity of prostate cancer.

The competition, organized by the Dutch Radboud University Medical Center and the Swedish Karolinska Institute, focuses on leveraging computer vision to automatically grade the severity of cancer in prostate tissue samples. Precise diagnostics are key in curing prostate cancer, which is the second most common cancer among men.

Computer vision is already improving diagnostics to become more precise, but there’s still work to do. How familiar are you with using computer vision in this type of healthcare context?

Joni: I have built computer vision algorithms for reading point-of-care test results. Still, it’s entirely different to quantify a tracer signal from a test strip than to interpret a biological tissue. However, we have also participated in other diagnostics competitions, like the diabetic retinopathy or the pneumothorax chest x-ray detection competitions which had some similarities in terms of understanding the treatment and diagnostics process. 

Mikko: In my previous job we were studying the capacities of computer vision in cancer diagnostics and recognizing different tumor types and even mutations in digitized tissue slide images. In addition, I have had several freelance projects, which aimed at automatising the diagnostics and grading of various eye diseases. Also the Kaggle competitions that Joni mentioned above would count as experience in the field.

What are some of the key learnings you’ve had so far in using computer vision to grade the severity of cancer?

Mikko: Although the competition is still ongoing, it already looks like we’re able to grade prostate cancer biopsies with machine learning, based on the current scores on the competition’s Leaderboard. This board shows all the teams participating and grades them according to their results. So far our own success has mainly been built on good data preprocessing. 

In the beginning of the project, we had a telco with a pathologist from Turku University Hospital (Tyks) to briefly explain the grading. This discussion provided us with a lot of insight of what features a human pathologist would seek when grading the severity in a prostate cancer biopsy.

Understandably you can’t reveal your solution yet, but could you describe some of the methods you’re using.

Joni: We are still tweaking the architecture and trying different approaches for handling such giant tissue slides. The method that is working decently so far is processing the slide in smaller tiles through a convolutional neural network (CNN) feature extractor and pooling the outputs from all tiles to a classification module.

Mikko: We both have some previously acquired domain knowledge on digital pathology. There are tricks, such as color deconvolution, that we can use to balance the color variations in the slides. These variations are typically caused by the different protocols and scanners that different laboratories might have for staining and scanning the biopsies. However for the computer vision model, these variations might be confusing, which is why we try to eliminate them.

Many machine learning challenges in healthcare involve a lot of data preprocessing. How do the particularities of the digitized biopsy data impact the training of the model?

Mikko: The (cancer) biopsy tissue slides, once scanned into digitized images are usually very large, extending from hundreds to thousands of megapixels in size. This is problematic when training the machine learning model. We have scripted different sampling methods to optimally extract smaller subimages from the tissue image. In addition, we have designed the machine learning architecture so that it can ingest a stack of these subimages, effectively covering the whole tissue slide for the analysis.

The large size of the images also leads to trouble in annotating, in other words, giving a label or a description for the data. Pathologists simply can’t thoroughly annotate the data. In addition, the opinion of two pathologists can differ: this can lead to noisy or unclear labels. As mentioned before, there are variations in the color distributions between the different diagnostic laboratories caused, for example, by different staining methods and scanners. If not properly taken into account when training the model, such discrepancies can lead to models not generalizing between the different laboratories and hospitals. Lastly, the data may not always be enough for a meaningful training since collecting the sensitive clinical data is obviously strictly regulated. 

Joni: I have trained models for detecting breast cancer from lymph node biopsy data in one previous Kaggle competition and for my master’s thesis. In my experience, the CNN models tend to recognize cancer at least as well as trained pathologists. As Mikko mentioned, stain appearances can vary from different scanners and preparation procedures, so it’s essential to add robustness against it to the solution through data augmentation or normalization.

Let’s talk about teamwork in your team rähmä.ai. How have you divided the work between the three of you?

Mikko and Joni: We have split the roles in the team very efficiently: some of us are focused on data preparation whereas others are more dedicated to model development and training. Because of the ongoing Covid-19 outbreak, we haven’t been able to have any face-to-face meetings. Instead, all our communication and idea baking has happened in the instant messaging tool Slack,and in occasional Hangouts meetings. Our code is shared between us in Github. Even so, it’s still been a blast to work together and keep our eyes on the big price – not the money or Kaggle-glory but finding new ways to defeat this cancer!


Image of Pertti Hannelin

Interested in knowing more about our smart health solutions? Get in touch with our VP, Business Development Pertti Hannelin at pertti.hannelin@silo.ai.


We are always interested to discuss more with curious computer vision experts like Joni and Mikko! Check out our open AI Scientist positions and apply directly here https://silo.ai/careers.

Share

Share on twitter
Share on facebook
Share on linkedin

Author

  • Pauliina Alanen Pauliina Alanen

Topics

AI for BusinessComputer Vision

You might be interested in

Close up of turning gears.

AI has become common, but will industry follow?

Peter Sarlin 18.7.2022

This article builds on Silo AI CEO Peter Sarlin’s op-ed in the leading Finnish commerce newspaper Kauppalehti. While the artificial intelligence hype is plateauing, AI has become a common part

Read More

Understanding today’s Edge AI

Mia Jokiluhta 7.7.2022

Similarly to AI, edge AI should be approached as an umbrella term. Edge AI is not a model but an entire technology stack. Like AI, there’s an incredible amount of

Read More

We challenge you to ask why

We don’t only deliver projects but we challenge you to think different.
Contact

Subscribe to Silo AI newsletter

Join 3000+ subscribers who read the Silo AI monthly newsletter

silo.ai
Contact

+358 40 359 1299

info@silo.ai

  • Helsinki, Finland
  • Stockholm, Sweden
  • Copenhagen, Denmark
Menu
  • Home
  • Services
  • Solutions
  • Research
  • Work
  • About
  • Careers
  • Contact
Menu
  • Home
  • Services
  • Solutions
  • Research
  • Work
  • About
  • Careers
  • Contact
Resources
  • Learn
  • Inference podcast
  • For media
  • MLOps
  • Predictive maintenance
  • Nordic State of AI report
Menu
  • Learn
  • Inference podcast
  • For media
  • MLOps
  • Predictive maintenance
  • Nordic State of AI report
Linkedin Facebook-square Twitter Instagram Spotify
©2017-2022 All Rights Reserved.

|

Website Privacy Policy / Cookie Policy / Newsletter Privacy Policy / Recruitment Privacy Policy

Manage cookies
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent. Read Cookie Policy
Cookie SettingsAccept All
Manage cookies

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT
Powered by CookieYes Logo